Cargando…

Comparison of disease progression subgroups in idiopathic pulmonary fibrosis

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial pneumonia with an unpredictable course. The aims of this study were to retrospectively re-evaluate a cohort of patients with IPF according to the 2011 international IPF guidelines and 1) to characterize the subgroups of pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kärkkäinen, Miia, Kettunen, Hannu-Pekka, Nurmi, Hanna, Selander, Tuomas, Purokivi, Minna, Kaarteenaho, Riitta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883511/ https://www.ncbi.nlm.nih.gov/pubmed/31783748 http://dx.doi.org/10.1186/s12890-019-0996-2

Ejemplares similares

Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis
por: Kärkkäinen, Miia, et al.
Publicado: (2017)

Underlying and immediate causes of death in patients with idiopathic pulmonary fibrosis
por: Kärkkäinen, Miia, et al.
Publicado: (2018)

Several specific high-resolution computed tomography patterns correlate with survival in patients with idiopathic pulmonary fibrosis
por: Mononen, Minna E., et al.
Publicado: (2021)

Are risk predicting models useful for estimating survival of patients with rheumatoid arthritis-associated interstitial lung disease?
por: Nurmi, Hanna M., et al.
Publicado: (2017)

Variable course of disease of rheumatoid arthritis-associated usual interstitial pneumonia compared to other subtypes
por: Nurmi, Hanna M., et al.
Publicado: (2016)

Reticulation pattern without honeycombing on high-resolution CT is associated with the risk of disease progression in interstitial lung diseases
por: Mononen, Minna, et al.
Publicado: (2022)

Characteristics of idiopathic pulmonary fibrosis -associated cough. a case-control study
por: Saari, Eeva, et al.
Publicado: (2023)

Decline in Mast Cell Density During Diffuse Alveolar Damage in Idiopathic Pulmonary Fibrosis
por: Salonen, Johanna, et al.
Publicado: (2021)

National data on prevalence of idiopathic pulmonary fibrosis and antifibrotic drug use in Finnish specialised care
por: Salonen, Johanna, et al.
Publicado: (2022)

Are physicians in primary health care able to recognize pulmonary fibrosis?
por: Purokivi, Minna, et al.
Publicado: (2017)

Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases
por: Salonen, Johanna, et al.
Publicado: (2020)

Inflammatory myositis-associated interstitial lung disease can be distinguished from that associated with other connective tissue diseases
por: Nurmi, Hanna M., et al.
Publicado: (2023)

The current position of surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis
por: Kaarteenaho, Riitta
Publicado: (2013)

Virtual communication is commonly used in Finnish interstitial lung disease multidisciplinary meetings
por: Salonen, Johanna, et al.
Publicado: (2023)

Tissue is an issue in the search for biomarkers in idiopathic pulmonary fibrosis
por: Kaarteenaho, Riitta, et al.
Publicado: (2015)

Demographics and survival of patients with idiopathic pulmonary fibrosis in the FinnishIPF registry
por: Kaunisto, Jaana, et al.
Publicado: (2019)

Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases
por: Salonen, Johanna, et al.
Publicado: (2020)

Pharmacological treatment of idiopathic pulmonary fibrosis – preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine
por: Myllärniemi, Marjukka, et al.
Publicado: (2015)

NHLRC2 expression is increased in idiopathic pulmonary fibrosis
por: Kreus, Mervi, et al.
Publicado: (2022)

Idiopathic pulmonary fibrosis - a systematic review on methodology for the collection of epidemiological data
por: Kaunisto, Jaana, et al.
Publicado: (2013)

The challenges in classifying rheumatoid arthritis-associated interstitial lung disease
por: Nurmi, Hanna, et al.
Publicado: (2020)

Extracellular matrix proteins produced by stromal cells in idiopathic pulmonary fibrosis and lung adenocarcinoma
por: Kreus, Mervi, et al.
Publicado: (2021)

Delay and inequalities in the treatment of idiopathic pulmonary fibrosis: the case of two Nordic countries
por: Pesonen, Ida, et al.
Publicado: (2018)

KIF15 missense variant is associated with the early onset of idiopathic pulmonary fibrosis
por: Hollmén, Maria, et al.
Publicado: (2023)

Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis
por: Kaunisto, Jaana, et al.
Publicado: (2015)

Pirfenidone and nintedanib modulate properties of fibroblasts and myofibroblasts in idiopathic pulmonary fibrosis
por: Lehtonen, Siri T., et al.
Publicado: (2016)

Cough-provocation tests with hypertonic aerosols
por: Koskela, Heikki O., et al.
Publicado: (2020)

Transcriptome Classification Reveals Molecular Subgroups in Idiopathic Pulmonary Fibrosis
por: Liu, Yuxia, et al.
Publicado: (2022)

Pet ownership supports quality of life in home‐dwelling people with Alzheimer's disease
por: Välimäki, Tarja, et al.
Publicado: (2022)

Identification of the Molecular Subgroups in Idiopathic Pulmonary Fibrosis by Gene Expression Profiles
por: Zhang, Ning, et al.
Publicado: (2021)

Factor analysis identifies three separate symptom clusters in idiopathic pulmonary fibrosis
por: Seppälä, Severi, et al.
Publicado: (2020)

Dyspnoea with progressive “idiopathic” pulmonary fibrosis
por: Puri, Chahat, et al.
Publicado: (2021)

Comment on Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults
por: Scholand, Mary Beth, et al.
Publicado: (2022)

Prognosis of combined pulmonary fibrosis and emphysema: comparison with idiopathic pulmonary fibrosis alone
por: Jiang, Chun-guo, et al.
Publicado: (2019)

Effect of Nintedanib in Patients with Progressive Pulmonary Fibrosis in Subgroups with Differing Baseline Characteristics
por: Kolb, Martin, et al.
Publicado: (2023)

Immune Inflammation and Disease Progression in Idiopathic Pulmonary Fibrosis
por: Balestro, Elisabetta, et al.
Publicado: (2016)

Temporal progression of mediastinal lymphadenopathy in idiopathic pulmonary fibrosis
por: Wallis, Tim JM, et al.
Publicado: (2022)

Progress of Statin Therapy in the Treatment of Idiopathic Pulmonary Fibrosis
por: Kou, Leiya, et al.
Publicado: (2022)

Diffuse Alveolar Damage: A Common Phenomenon in Progressive Interstitial Lung Disorders
por: Kaarteenaho, Riitta, et al.
Publicado: (2011)

Re-hospitalisation predicts poor prognosis after acute exacerbation of interstitial lung disease
por: Salonen, Johanna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5nhvlptl85tp8f6ukpl24ftngs